[1]
J. L. Miguel Reyes, “Benralizumab in severe eosinophilic asthma: A real-world, single-center, observational study from Mexico”, Allergol Immunopathol, vol. 51, no. 6, pp. 8–15, Nov. 2023, doi: 10.15586/aei.v51i6.852.